Gerresheimer AG (ETR:GXI – Get Free Report) shares traded up 0.3% on Monday . The company traded as high as €29.40 and last traded at €29.06. Approximately 116,701 shares were traded during trading, a decline of 17% from the average session volume of 140,925 shares. The stock had previously closed at €28.96.
Gerresheimer Stock Performance
The firm has a market capitalization of $994.92 million, a price-to-earnings ratio of 8.70, a P/E/G ratio of 0.82 and a beta of 0.47. The company has a 50-day moving average price of €26.90 and a 200-day moving average price of €23.84. The company has a quick ratio of 0.40, a current ratio of 0.81 and a debt-to-equity ratio of 147.98.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
See Also
- Five stocks we like better than Gerresheimer
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.
